Atrogi welcomes Anders Ekblom as the new chairman of the board.
Anders Ekblom has extensive experience as an executive and leader with broad business knowledge from senior roles in the biopharmaceutical industry, with global experience delivering products, projects, productivity and change management.
He is currently Chairman/Non-Executive Board member of several biotech companies namely AnaMar AB, Alligator Bioscience AB, Elypta AB, Mereo BioPharma Group Plc, and Xspray Pharma AB.
During two decades at AstraZeneca, Anders was a member of global executive teams including being Executive VP Global Medicines Development, Global Head Clinical Development, Global Therapy Area Head, and CEO.
Anders is also a board-certified MD (Anaesthesiology and Intensive Care), PhD, DDS, and Associate Professor at Karolinska Institute, Stockholm, Sweden, and a fellow of the Royal Swedish Academy of Engineering Sciences.